Risk Factors for Relapse in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Among Patients With Relapse After Induction of Remission With Rituximab is a research paper published in Arthritis & Rheumatology (2025). On theSindex it has a DataRank of 0.165. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.165
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: 5T32‐AR076951‐05
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: U54 AR057319
National Institutes of Health
Grant: 5T32GM075766‐17
Rehabilitation Research and Development Service
Grant: RX003644
Rehabilitation Research and Development Service
Grant: RX004770
Versus Arthritis
Grant: 18706
Roche
Grant: MA28150
National Center for Research Resources
Grant: U54 RR019497
RRD VA
Grant: I01 RX004770
NIAMS NIH HHS
Grant: 5T32-AR076951-05
RRD VA
Grant: I01 RX003644
NIH HHS
Grant: 5T32GM075766-17
NIGMS NIH HHS
Grant: T32 GM075766
NIAMS NIH HHS
Grant: T32 AR076951
MeSH Terms